NCT04140721View on ClinicalTrials.gov

Autonomic Determinants of POTS - Pilot 2

EARLY_PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

August 31, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Postural Tachycardia Syndrome
Interventions
DRUG

Placebo oral tablet

Placebo pill identical to moxonidine administered for 4 weeks

DRUG

Moxonidine Pill

Moxonidine pill administered for 4 weeks

Trial Locations (1)

37221

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Vanderbilt University Medical Center

OTHER